Trial intelligence / Profile preview

Clonidine Lauriad for Oral Mucositis in Head and Neck Cancer

NCT01385748Phase 2Completed

Sponsor
Valerio Therapeutics
Start
Apr 2010
Primary completion
Oct 2014
Modality
Small Molecules, Device-based Delivery
Countries
6
01

Overview

A Phase 2 trial of Clonidine Lauriad in oral mucositis (OM), sponsored by Valerio Therapeutics. Started Apr 2010; status: completed.

02

Drugs

Clonidine Lauriad
03

Conditions

oral mucositis (OM)

Beyond the preview

Go deeper on NCT01385748.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01385748.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call